Metronidazole HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 16 USDMF, 11 CEP/COS, 1 JDMF, 1 EU WC, 14 KDMF, 11 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

386 FDF Dossiers, 115 FDA Orange Book, 87 Europe, 19 Canada, 10 Australia, 48 South Africa, 107 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 500MG, INJECTABLE;INJECTION - 500MG/100ML, INJECTABLE;INJECTION - 500MG/100ML, GEL;TOPICAL - 0.75%, GEL;VAGINAL - 0.75%, GEL;VAGINAL - 1.3%, CREAM;TOPICAL - 0.75%, SUSPENSION;ORAL - 500MG/5ML, GEL;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 11 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 1 Clariant, 17 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Lubrizol Life Science Health, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 45 Thickeners and Stabilizers, 43 Direct Compression, 40 Solubilizers, 35 Controlled & Modified Release, 33 Topical, 33 Disintegrants & Superdisintegrants, 27 Granulation, 23 Parenteral, 23 Film Formers & Plasticizers, 20 Lubricants & Glidants, 19 Co-Processed Excipients, 18 Taste Masking, 11 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 5 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 55 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 83 Finished Drug Prices

MARKET PLACE

65 APIs, 40 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 11 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 216755 / DOSAGE - SUSPENSION;ORAL - 500MG/5ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
metronidazole(UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E)	metronidazole	100mg in 1

Inactive Ingredients

Ingredient Name	Kesin Pharma Corporation
GLYCERIN(PDC6A3C0OX)
MAGNESIUM ALUMINUM SILICATE(6M3P64V0NC)
METHYLPARABEN(A2I8C7HI9T)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
PEPPERMINT(V95R5KMY2B)
PROPYLPARABEN(Z8IX2SC1OH)
SODIUM PHOSPHATE DIBASIC DIHYDRATE(94255I6E2T)
SODIUM PHOSPHATE, MONOBASIC(3980JIH2SW)
STRAWBERRY(4J2TY8Y81V)
SUCRALOSE(96K6UQ3ZD4)
SUCROSE(C151H8M554)
WATER(059QF0KO0R)

Drug Product Composition: Metronidazole HCl